Telmisartan 40 mg + Chlorthalidone 6.25 mg is a combination medicine used to help control high blood pressure in patients for whom treatment with both ingredients is appropriate. Telmisartan works by blocking angiotensin II receptors, which helps blood vessels relax and reduces resistance to blood flow. Chlorthalidone is a thiazide-like diuretic that helps the kidneys remove excess sodium and water, contributing to lower blood pressure.
By working through different mechanisms, the two ingredients may provide complementary blood pressure control. Keeping blood pressure within the range recommended by a healthcare professional can help reduce the long-term risk of complications such as stroke, heart attack, and other cardiovascular problems.
Possible side effects include dizziness, light-headedness, increased urination, dehydration, and changes in blood electrolyte levels. Telmisartan may increase potassium levels or affect kidney function in some patients, whereas chlorthalidone may lower potassium or sodium. The risk depends on individual health conditions, other medicines, and treatment response.
कैसे उपयोग करें
Follow your prescription: Take only the dose recommended by your healthcare professional. Do not change the dose or combine it with another blood pressure medicine without medical advice.
Take it consistently: If your prescription specifies once-daily use, take the tablet at approximately the same time each day to help maintain a regular routine.
Follow food instructions: Take the medicine with or without food according to the specific product leaflet. Swallow the tablet with water.
If you miss a dose: Take it when you remember unless it is nearly time for your next dose. If the next dose is near, skip the missed dose and resume your usual schedule. Do not double the dose.
Monitor your blood pressure: Check your readings as advised by your doctor and attend scheduled follow-up appointments.
Attend blood tests when advised: Your doctor may monitor kidney function, potassium, sodium, and other electrolytes because both ingredients can affect these measurements.
Maintain appropriate hydration: Chlorthalidone increases urine production. Follow your clinician's fluid-intake advice, particularly during hot weather or if you experience vomiting or diarrhoea.
Review other medicines: Tell your doctor about all medicines and supplements you use, especially potassium supplements, lithium, other blood pressure medicines, and anti-inflammatory painkillers such as ibuprofen.
Do not stop treatment independently: High blood pressure may have no obvious symptoms. Continue treatment unless your healthcare professional advises otherwise.
Recognise warning signs: Seek urgent medical help for fainting, severe weakness, an irregular heartbeat, or signs of significant dehydration.
भंडारण
Store in cool and dry place
Important guidance
Safety advice
Check with your doctor
AlcoholConsult your doctor
Alcohol may increase the blood-pressure-lowering effect of Telmisartan 40 mg + Chlorthalidone 6.25 mg, potentially causing dizziness, light-headedness, or fainting. Excessive alcohol consumption may also worsen dehydration. Avoid heavy drinking, particularly when starting treatment, and ask your doctor whether alcohol is appropriate for your medical condition.
PregnancyConsult your doctor
Telmisartan 40 mg + Chlorthalidone 6.25 mg should not be used during pregnancy because telmisartan can harm the developing baby, particularly during the second and third trimesters. Inform your doctor immediately if you become pregnant or plan to conceive. Your healthcare professional should arrange an appropriate alternative treatment promptly.
BreastfeedingConsult your doctor
Breastfeeding while taking Telmisartan 40 mg + Chlorthalidone 6.25 mg requires medical assessment. Information about telmisartan during breastfeeding is limited, and chlorthalidone may enter breast milk and potentially reduce milk production, particularly at higher doses. Ask your doctor about suitable alternatives based on your condition and your baby's age and health.
DrivingConsult your doctor
Telmisartan 40 mg + Chlorthalidone 6.25 mg may cause dizziness, light-headedness, or weakness, particularly when starting treatment or when blood pressure becomes too low. Chlorthalidone-related dehydration may also affect alertness. Avoid driving or operating machinery until you know how the medicine affects you, and do not drive if you feel faint or dizzy.
KidneyConsult your doctor
Patients with kidney disease should take Telmisartan 40 mg + Chlorthalidone 6.25 mg under medical supervision. Telmisartan can affect kidney function and potassium levels, while chlorthalidone may cause dehydration and electrolyte disturbances. Your doctor may monitor kidney function, sodium, and potassium before and during treatment. Severe kidney impairment may make this combination unsuitable.
LiverConsult your doctor
Inform your doctor if you have liver disease before taking Telmisartan 40 mg + Chlorthalidone 6.25 mg. Significant liver impairment may increase the risk of complications associated with fluid or electrolyte changes and low blood pressure. Your healthcare professional should assess your liver condition and determine whether this combination is appropriate or an alternative treatment is needed.
Clinical review pending
This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.
